Company profile for AXIM

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our company was formed in September 1998 and was awarded the sole distribution rights in sub-Saharan Africa for the Shimadzu and Aloka products. Since September 1998, we have focused on establishing an experienced engineering and sales base both to service the existing 1450 Shimadzu and Aloka clients as well as to establish new clientele. AXIM Group acquired Marcus Medical in 2007 and we are the sole distributor for Cook Med...
Our company was formed in September 1998 and was awarded the sole distribution rights in sub-Saharan Africa for the Shimadzu and Aloka products. Since September 1998, we have focused on establishing an experienced engineering and sales base both to service the existing 1450 Shimadzu and Aloka clients as well as to establish new clientele. AXIM Group acquired Marcus Medical in 2007 and we are the sole distributor for Cook Medical and provider of interventional consumables across nine difference medical modalities. This Company also supplies surgical, disposables, instrumentation and hospital equipments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Africa
Address
Address
AXIM House, 63 Old Pretoria Road, Halfway House, Ext. 2, Midrand
Telephone
Telephone
27 11 314 0140
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/07/26/2486010/33692/en/AXIM-Biotechnologies-Enhances-IgE-Testing-Capabilities-Responds-to-Global-Warming-s-Impact-on-Allergy-Season.html

GLOBENEWSWIRE
26 Jul 2022

https://www.globenewswire.com/news-release/2022/07/12/2478178/33692/en/AXIM-Biotechnologies-Publishes-Study-Highlighting-Neutralizing-Antibody-Levels-of-Poor-Vaccine-Responders-with-a-Third-COVID-19-Vaccine-Dose.html

GLOBENEWSWIRE
12 Jul 2022

https://www.globenewswire.com/news-release/2022/06/02/2455281/33692/en/AXIM-Launches-New-Eye-Care-Website-Establishes-Platform-for-Commercialization.html

GLOBENEWSWIRE
02 Jun 2022

https://www.globenewswire.com/news-release/2022/05/24/2449460/33692/en/AXIM-Biotechnologies-Completes-Optimization-of-Only-FDA-Cleared-IgE-Rapid-Diagnostics-Test-In-House-Manufacturing-Lowers-Cost-and-Eliminates-Supply-Chain-Expenditures.html

GLOBENEWSWIRE
24 May 2022

https://www.globenewswire.com/news-release/2022/05/10/2439840/33692/en/AXIM-Biotechnologies-Develops-Novel-Tear-Sample-Collector-System-Files-Patent-Application.html

GLOBENEWSWIRE
10 May 2022

https://www.globenewswire.com/news-release/2022/04/27/2430303/33692/en/AXIM-Develops-Quantitative-Rapid-Diagnostic-Test-for-Lacritin-Now-Boasts-Four-Dry-Eye-Disease-Point-of-Care-Biomarker-Tests.html

GLOBENEWSWIRE
27 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty